IGF1 and intrahepatic cholangiocarcinoma: While interventions targeting the ERK signaling pathway and the proliferation of ICC-SC, such as IGF1, may be valuable in mitigating age-related GI dysfunctions, the role of the ICC in the intestines remains unclear and warrants further investigation.